New Report Shines Light on Impact of Bladder Health on Social Participation, Economic Productivity and Workforce Engagement

Global Coalition on Aging Calls for Increased Awareness, More Effective Treatments for Overactive Bladder, a Hidden Barrier to Active Aging for Millions of Older Adults

NEW YORK, NY (21 February 2018) – Today the Global Coalition on Aging (GCOA) released a new report titled, “Bladder Health and Active Aging: Overcoming Stigma and Innovating Treatments as We Age.” The report highlights the impact bladder health can have on quality of life as one ages and stresses the need for greater awareness of and new, innovative treatment options for overactive bladder (OAB), an increasingly debilitating, yet often unrecognized and under-addressed condition of aging.

“As overactive bladder grows in prevalence among the age 60-plus population, it unfortunately is too often accepted as one of those inevitable parts of aging,” said GCOA CEO Michael W. Hodin, PhD. “We must eliminate the stigma associated with OAB and other conditions of aging and simultaneously encourage innovation in the prevention and treatment of these conditions so that the subtle if profound barriers to active aging, social engagement and workforce participation among older adults are not seen as normal.”

Thirty million Americans are currently living with symptoms of OAB, and while the prevalence of overactive bladder does increase with age, it does not have to be a normal part of the aging process, particularly as therapies and treatments do exist to address it and new innovations are being pursued.  Research questions remain, especially regarding the impact of OAB on people over age 60, however data shows that three-quarters of people with OAB find it more difficult to complete daily activities, resulting in decreased physical activity and weight gain because of an inability to exercise. Nearly one-third report feelings of depression and high levels of stress.

For working older adults, OAB also has an impact on their ability to be productive and engaged in their workplaces:  21 percent of people with the condition fear interrupting meetings due to their bladder symptoms, and 5 percent reporting they have left the workforce earlier than planned because of OAB.  In the United States alone, that equates to 2.6 million skilled and experienced professionals that have exited the workforce due to OAB.  The effects on individuals, families, employers, and communities in the United States alone adds up to $65.9 billion in annual costs.  At a time when our health system is desperate for cost savings, GCOA argues that we should be targeting these kinds of conditions for wellness and treatment and thereby re-imagining how we age.

The report found that while treatments for OAB do exist, they are neither practical for older adults nor have they been proven adequately effective in treating OAB.  The most common treatment prescribed today is a group of drugs called anticholinergics. Unfortunately, one study shows that 92 percent of patients using these drugs to treat OAB failed initial treatment within two years, and 82 percent stopped taking the drugs due to factors such as unmet treatment expectations and negative side effects.  These drugs have, in fact, been shown by years of research and in-market experience to have adverse effects on cognitive health, and recent studies have linked their use to an increased risk of dementia and damage to the central nervous system.

“Even though more research needs to be conducted to fully understand the long-term effects of these OAB treatments, the data showing the correlation between anticholinergics and cognitive side effects is quite clear,” said Dr. Michael Chancellor, Professor of Urology, Beaumont Health System and Oakland University William Beaumont School of Medicine.  “We must do better for patients dealing with this stigmatized and often overlooked condition and must encourage innovation for new and better treatment options.”

The report also underscored that the stigma associated with conditions like OAB increases with age. This stigma related to loss of control of the body leads to social interruption and can serve as a barrier to seeking treatment.  GCOA is calling for greater public health attention to addressing bladder health as a condition of aging that can be prevented, treated, and/or marginalized as a part of a healthier and more active approach to aging.  Employment and social policy, retirement plans, fiscal policy, healthcare, and public service delivery are among the ways policymakers can comprehensively promote active aging.

“We have a great deal of evidence disproving the assumption that a decline in the health of our skin, vision, hearing, bone and muscle mass, and bladder are inevitable as we age,” said Hodin. “Addressing OAB through awareness to reduce stigma, an active aging agenda to address prevention, and new and better interventions to treat the condition will go a long way toward changing perceptions of aging and ensuring better quality of life for us all as we age.”

Click here to read the report.

 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.